Hello, Welcome to icliniq.com. I read your query and can understand your concern. For a 4-year-old child with human metapneumovirus (HMPV) infection, the following are potential reasons to visit the emergency room (ER). Respiratory Distress: Severe respiratory distress: Indicated by grunting, wheezing, or making unusual sounds while breathing. Respiratory rate more than 40 breaths per minute: Elevated respiratory rate.
Hello, Welcome to icliniq.com. I have read your query and can understand your concern. At reputable centers, it is common practice to vaccinate patients with pneumococcal and flu vaccines either before or during the perioperative period (around the time of the splenectomy), if possible. I recommend reviewing your medical records and discharge notes to verify if these vaccines were administered. As you have had a splenectomy, you are at a higher risk for pneumococcal infections, and it is important to manage this risk carefully.
Hello, Welcome to icliniq.com. I understand your concerns about the recurrence of breast cancer and the challenges you are facing with treatment. The recurrence of stage 2 lobular breast cancer in the opposite breast with a different subtype, invasive lobular carcinoma, is not uncommon. The presence of an ATM gene variant may contribute to an increased risk of developing breast cancer. Various factors, including genetic mutations, hormonal influences, and environmental exposures, can lead to different breast cancer subtypes in the same person.
Hello, Welcome to icliniq.com. I have read your query and can understand your concern. For your confirmation of breast cancer diagnosis, the following things can be done: First is the type of breast cancer. You have been diagnosed with pregnancy-associated breast cancer, which occurs during pregnancy or within a year of giving birth. Then stage and grade.
Hello, Welcome to icliniq.com. I can understand your concern. Triple-negative breast cancer can be challenging, but with the right treatment approach, many patients achieve favorable outcomes. Hair loss is a common side effect of chemotherapy, but cooling caps, also known as scalp cooling systems, may help reduce it by lowering scalp temperature and minimizing the impact on hair follicles. Chemotherapy for triple-negative breast cancer typically lasts several months, so your oncologist can provide a more detailed treatment timeline.
Hello, Welcome to icliniq.com. I read your query and can understand your concern. To gain a clearer understanding of your condition, please submit the following comprehensive clinical history and reports: Clinical History 1. Asthma background: Indicate the age of onset, severity, and any past hospitalizations or admissions to the intensive care unit (ICU). 2.
Hello, Welcome to icliniq.com. I read your query and can understand your concern. Inflammatory breast cancer(IBC) is a rare and highly aggressive type of breast cancer. Understanding the progression of IBC and the impact of chemotherapy is crucial given her diagnosis and symptoms. Symptom Progression and Chemotherapy Initial symptom exacerbation: It is common for symptoms such as redness, swelling, and skin irritation to intensify before showing improvement, particularly during the early phases of chemotherapy.
Hi, Welcome to icliniq.com. I can understand your concern. Skincare and itching relief Topical creams: Over-the-counter creams like Hydrocortisone, Calamine lotion, or aloe vera gel can help soothe itchy skin. Moisturizers: Use gentle, fragrance-free moisturizers to keep your skin hydrated. Cool compresses: Apply cool, wet compresses to itchy areas to reduce discomfort.
Hello, Welcome to icliniq.com. I understand your concern. Possible causes and risk factors- 1. Healthcare work: While working in healthcare does not directly cause bladder cancer, exposure to certain chemicals, such as those used for sterilization, may increase the risk. 2.
Hi, Welcome to icliniq.com. I have gone through your query and understand your concern. Recurrence risk: Non-muscle invasive bladder cancer (NMIBC) has a significant risk of recurrence, even after successful initial treatment. Recurrence rates: Studies suggest that the recurrence rate for NMIBC is around 50 to 70% within 5 years of initial treatment. Progression risk: Approximately 10 to 20% of patients with NMIBC may experience progression to muscle-invasive disease.
Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.